Mirae Asset Global ETFs Holdings’s Madrigal Pharmaceuticals MDGL Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Sell	1,929 -8,149	-81%	-$4.17M	﹤0.01%	1616
2026 Q1	$5.26M	Sell	10,078 -483	-5%	-$231K	0.01%	809
2025 Q4	$6.15M	Sell	10,561 -795	-7%	-$406K	0.01%	751
2025 Q3	$5.19M	Sell	11,356 -1,133	-9%	-$423K	0.01%	801
2025 Q2	$3.78M	Sell	12,489 -1,369	-10%	-$408K	0.01%	823
2025 Q1	$4.59M	Sell	13,858 -304	-2%	-$99.9K	0.01%	785
2024 Q4	$4.37M	Buy	14,162 +138	+1%	+$38.8K	0.01%	813
2024 Q3	$2.98M	Buy	14,024 +5,070	+57%	+$1.3M	0.01%	941
2024 Q2	$2.52M	Buy	+8,954	New	+$2.13M	0.01%	979

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's MDGL Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Madrigal Pharmaceuticals (MDGL) stake by 81% in Q2 2026, selling an estimated $4.17M and leaving 1,929 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #1616.

Mirae Asset Global ETFs Holdings first reported a position in MDGL in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.15M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Mirae Asset Global ETFs Holdings held 1,929 shares of Madrigal Pharmaceuticals worth $1.03M as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 8,149 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $4.17M.
Madrigal Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1616 holding.
Mirae Asset Global ETFs Holdings first reported a position in Madrigal Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Madrigal Pharmaceuticals position peaked at $6.15M in Q4 2025.
414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.